Orchard Therapeutics raised $150M in a Series C funding led by Deerfield Capital Management. Other participants of this round included Sphera Global Healthcare Fund, Driehaus Capital Management. Cowen Healthcare Investments, RTW Investments LLC, Agent Capital, ArrowMark Partners, Baillie Gifford, Foresite Capital, Perceptive Advisors, Cormorant Asset Management, RA Capital Management, Temasek Holdings, and Venrock. This biotech company focused on gene therapy and stem cell research was founded by Andrea Spezzi and Ben Auspitz, it has now raised a total of $310.5M.
Page 2 of 5
